tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MOLN Stock Latest News

Molecular Partners AG (ADR) trading resumes
The FlyMolecular Partners AG (ADR) trading resumes
1M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
1M ago
MOLN
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
PremiumThe Fly
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
1M ago
MOLN
Molecular Partners Advances Therapeutic Platforms
PremiumCompany Announcements
Molecular Partners Advances Therapeutic Platforms
1M ago
6K
MOLN
Molecular Partners AG (ADR) trading resumes
PremiumThe Fly
Molecular Partners AG (ADR) trading resumes
2M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe FlyMolecular Partners AG (ADR) trading halted, volatility trading pause
2M ago
MOLN
Molecular Partners AG (ADR) trading resumes
Premium
The Fly
Molecular Partners AG (ADR) trading resumes
4M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
Premium
The Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
4M ago
MOLN
Molecular Partners’ New Therapy Shows AML Treatment Promise
PremiumCompany Announcements
Molecular Partners’ New Therapy Shows AML Treatment Promise
4M ago
6K
MOLN
Molecular Partners announces preclinical data from MP0621 trial
PremiumThe Fly
Molecular Partners announces preclinical data from MP0621 trial
4M ago
MOLN
Molecular Partners Unveils Promising Cancer Therapy
PremiumCompany Announcements
Molecular Partners Unveils Promising Cancer Therapy
4M ago
6K
MOLN
Molecular Partners, Orano Med present MP0712 data at SNMMI
PremiumThe Fly
Molecular Partners, Orano Med present MP0712 data at SNMMI
4M ago
MOLN
Molecular Partners’ MP0317 Shows Promising Trial Results
PremiumCompany AnnouncementsMolecular Partners’ MP0317 Shows Promising Trial Results
4M ago
6K
MOLN
Molecular Partners presents data from completed Phase 1 trial of MP0317
Premium
The Fly
Molecular Partners presents data from completed Phase 1 trial of MP0317
4M ago
MOLN
Molecular Partners Ag Advances Clinical Pipeline
Premium
Company Announcements
Molecular Partners Ag Advances Clinical Pipeline
5M ago
6K
MOLN
Molecular Partners Sets Date for 2024 AGM
PremiumCompany Announcements
Molecular Partners Sets Date for 2024 AGM
7M ago
6K
MOLN
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
PremiumThe Fly
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
9M ago
MOLN
Molecular presents data from dosing cohorts of Phase 1/2a trial of MP0533
PremiumThe Fly
Molecular presents data from dosing cohorts of Phase 1/2a trial of MP0533
10M ago
MOLN
Molecular Partners price target lowered by CHF 2 at JPMorgan
PremiumThe Fly
Molecular Partners price target lowered by CHF 2 at JPMorgan
10M ago
MOLN
Molecular Partners price target lowered by $2.10 at JPMorgan, here’s why
PremiumThe FlyMolecular Partners price target lowered by $2.10 at JPMorgan, here’s why
10M ago
MOLN
Molecular Partners present updated data from Phase 1 trial of MP0317
Premium
The Fly
Molecular Partners present updated data from Phase 1 trial of MP0317
11M ago
MOLN
Molecular Partners sees FY23 total expenses of CHF 65-70
Premium
The Fly
Molecular Partners sees FY23 total expenses of CHF 65-70
12M ago
MOLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >